The Institute of Medicine of the National Academies (IOM) on Monday released a summary of a workshop, titled “Country-Level Decision Making for Control of Chronic Diseases.” As part of a series of follow-up activities to the IOM’s 2010 report, “Promoting Cardiovascular Health in the Developing World,” the workshop “aimed to identify what is needed to create tools for country-led planning of effective, efficient, and equitable provision of programs to prevent and reduce the burden of chronic diseases,” according to its website (4/2).
Non Communicable Disease/Chronic Disease
IPS Reports On Research Study Examining Knowledge, Beliefs Of Cervical Cancer Among Argentinian Women
Inter Press Service reports on a research study conducted in Argentina that “explored women’s knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies.” The news service writes, “Although there are now effective tools to prevent cervical cancer, and vaccination against human papillomavirus (HPV) is free and mandatory for 11-year-old girls, the death rate from cervical cancer is not declining in Argentina, and the geographical distribution of the burden is extremely unequal.”
New York Mayor Michael Bloomberg on Thursday announced his charitable foundation will “spend $220 million over the next four years to discourage tobacco use in developing countries, as he seeks to promote strategies around the world that curbed smoking in his city,” the Wall Street Journal reports (McKay, 3/21). Bloomberg announced “the new funding for Bloomberg Philanthropies on Thursday at the 15th World Conference on Tobacco or Health in Singapore,” Reuters writes, noting “[t]he commitment takes the foundation’s total pledge to the cause to almost $600 million” (Begley et al., 3/22).
This week the WHO brought together lawmakers from across Southeast Asia in Bangkok “to discuss how to bolster their health systems back home,” IRIN reports. Meeting participants were “called on to advocate the boosting of health spending, workforces and access to health care in their home countries in addition to drafting ‘healthy public policies,’ such as conducting health assessments before large infrastructural projects are undertaken,” the news service writes.
Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her “Global Health Blog,” writing, “Children die from cancer, heart disease and other [NCDs] but they are in danger of being forgotten as global targets for action are drawn up, say health groups.” Boseley discusses an analysis by advocate Kate Armstrong, which suggests “the targets now being considered by the [WHO] and others to reduce the impact of heart disease, cancer and other [NCDs] are in danger of being focused solely on adults,” as “the targets under consideration aim to bring down the deaths of adults over the age of 30.”
A global report (.pdf) published by the WHO, titled “Mortality Attributable to Tobacco,” “provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex,” the agency’s website states (March 2012). According to the U.N. News Centre, the report “shows that five percent of all deaths from communicable diseases worldwide and 14 percent of deaths resulting from non-communicable illnesses among adults aged 30 and above were attributable to tobacco use” (3/15).
The Associated Press/Seattle Times reports on a “mysterious epidemic [that] is devastating the Pacific Coast of Central America, killing more than 24,000 people in El Salvador and Nicaragua since 2000 and striking thousands of others with chronic kidney disease at rates unseen virtually anywhere else.” The news service provides statistics regarding kidney disease in various Central American countries, quotes a number of experts regarding potential causes of the disease and notes, “While some of the rising numbers may be from better record-keeping, scientists believe they are facing something deadly and previously unknown to medicine.”
The “improvement and extension of health care in Africa is … being constrained by gaps in financing,” according to a new report (.pdf) by the Economist Intelligence Unit (EIU) based on research commissioned by Janssen Pharmaceutica, a Belgian subsidiary of Johnson & Johnson, the Financial Times’ “beyondbrics” blog reports (Wheatley, 3/1). The report, titled “The Future of Healthcare in Africa,” “discusses the continent’s traditional health care issues, such as communicable diseases or financing health care in economically difficult circumstances” and “also addresses less well-known topics, such as the threat of obesity and heart disease, the use of mobile technology, development of more preventive care, and more,” according to the Janssen website (3/1). The report “identif[ies] the key trends shaping African health care systems” and uses them “to develop [five] scenarios that depict the possible health landscape on the continent in 2022,” a Janssen press release (.pdf) states (3/1).
The March issue of the WHO Bulletin features an editorial on global shortages of medicines; a public health round-up; an article on breast cancer awareness; a research paper on interventions for the prevention of mother-to-child HIV transmission in Kwa-Zulu Natal, South Africa; and a paper on the global burden of cholera (March 2012).
“For mental health to gain significant attention, and funding from policymakers globally, it is not enough to convince people that it has a high disease burden but also that there are deliverable and cost-effective interventions — according to South African researchers writing in this week’s PLoS Medicine,” a PLoS press release reports, adding, “Mark Tomlinson and Crick Lund from the Department of Psychiatry and Mental Health based at the University of Cape Town argue that global mental health must demonstrate its social and economic impact.” According to the press release, the authors “discuss a framework to help understand why some global health initiatives are more successful in generating funding and political priority than others” (2/28).